Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qiji Guo

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Experimental Hematology & Oncology|August 5, 2024
Small cell lung cancer: emerging subtypes, signaling pathways, and therapeutic vulnerabilitiesJing Zhang, Xiaoping Zeng, Qiji Guo, et al.
Medcomm|June 8, 2026
Inducible T Cell Costimulator Ligand and Inducible T Cell Costimulator Stratification Identify Dichotomous Tumor Microenvironment and Guide Chemo-Immunotherapy in Small Cell Lung CancerQiji Guo, Yan Chen, Jijun Sun, et al.
Journal of Medical Virology|August 20, 2025
High Cytomegalovirus Load Is Associated With More Severe CMV-Associated Thrombocytopenia: A 6-Year Study in Eastern ChinaQiji Guo, Yuhang Wu, Hao Xu, et al.
British Journal of Cancer|January 11, 2024
Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancerXiaohe Su, Kaifeng Jin, Qiji Guo, et al.
Eclinicalmedicine|January 1, 2026
Efficiency and safety of sintilimab-based induction therapy in potentially resectable stage III non-small cell lung cancer (LungMate-009): an open-label, phase 2 trialTao Ge, Hongyi Zhang, Xinsheng Zhu, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Experimental Hematology & Oncology|August 5, 2024
Small cell lung cancer: emerging subtypes, signaling pathways, and therapeutic vulnerabilitiesJing Zhang, Xiaoping Zeng, Qiji Guo, et al.
Medcomm|June 8, 2026
Inducible T Cell Costimulator Ligand and Inducible T Cell Costimulator Stratification Identify Dichotomous Tumor Microenvironment and Guide Chemo-Immunotherapy in Small Cell Lung CancerQiji Guo, Yan Chen, Jijun Sun, et al.
Journal of Medical Virology|August 20, 2025
High Cytomegalovirus Load Is Associated With More Severe CMV-Associated Thrombocytopenia: A 6-Year Study in Eastern ChinaQiji Guo, Yuhang Wu, Hao Xu, et al.
British Journal of Cancer|January 11, 2024
Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancerXiaohe Su, Kaifeng Jin, Qiji Guo, et al.
Eclinicalmedicine|January 1, 2026
Efficiency and safety of sintilimab-based induction therapy in potentially resectable stage III non-small cell lung cancer (LungMate-009): an open-label, phase 2 trialTao Ge, Hongyi Zhang, Xinsheng Zhu, et al.
Pageof 1